Document Classification

Section Type: RESULTS

Text: Compared with placebo, women receiving the active treatment had similar risk of developing total invasive cancer (101. 1 / 10, 000 person-years for the active treatment group vs 104. 3 / 10, 000 person-years for placebo group ; hazard ratio [HR], 0. 97 ; 95 % confidence interval [CI], 0. 79-1. 18 ; P =. 75), breast cancer (37. 8 / 10, 000 person-years vs 45. 6 / 10, 000 person-years, respectively ; HR, 0. 83 ; 95 % CI, 0. 60-1. 14 ; P =. 24), or any cancer death (24. 6 / 10, 000 person-years vs 30. 1 / 10, 000 person-years, respectively ; HR, 0. 82 ; 95 % CI, 0. 56-1. 21 ; P =. 32).